- Home
- IMCC vs RDHL Comparison
IMCC vs RDHL Comparison
Compare IMCC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMCC | RDHL |
|---|---|---|
| Founded | 1980 | 2009 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 3.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMCC | RDHL |
|---|---|---|
| Price | $1.48 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 293.7K | 69.2K |
| Earning Date | 11-13-2025 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,606,703.00 | $9,550,000.00 |
| Revenue This Year | $47.12 | $381.91 |
| Revenue Next Year | $12.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.92 | ★ 157.62 |
| 52 Week Low | $0.93 | $1.01 |
| 52 Week High | $7.12 | $7.00 |
Technical Indicators
Market Signals| Indicator | IMCC | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 44.23 |
| Support Level | $1.41 | $1.15 |
| Resistance Level | $1.91 | $1.24 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 13.04 | 8.79 |
Price Performance
Historical ComparisonAbout IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.